Pathway co-founder Dr. Louis Mullie co-authors BMJ analysis paper on AI in bedside care during COVID-19
Dr. Louis Mullie, Co-Founder and Chief Medical Officer at Pathway, has co-authored an analysis paper in the British Medical Journal (BMJ) on the impact of artificial intelligence (AI) for bedside care during COVID-19 and future pandemics.